vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

TherapeuticsMD, Inc. (NYSE MKT: TXMD) ("TherapeuticsMD" or the "Company"), a women's healthcare company and parent company of vitaMedMD, LLC ("vitaMedMD"), announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx. vitaPearl is a pearl-shaped softgel that is currently the smallest complete prescription prenatal multivitamin and the first to contain vitaMedMD's proprietary ingredients of FOLMAX™ (immediate and modified release folic acid), FePlus™ (ferrous fumarate and ferric sodium EDTA), an iron combination containing a chelated iron, and pur-DHA™ (docosahexaenoic acid) among its14 vitamins and minerals.

vitaPearl offers women who are planning a pregnancy, pregnant, or nursing a complete prenatal multivitamin in one tiny pearl-shaped softgel and offers providers and payors a unique high-value, high-quality prenatal solution.

John Milligan, President of the Company, stated, "vitaMedMD has once again listened and responded to the needs of the medical community for comprehensive nutritional support in the prenatal sector. On the heels of the success of vitaMedMD's currently available prescription prenatal vitamins, the introduction of vitaPearl and the Company's innovative proprietary ingredients not only provide patients with significant benefits, but also with the effective combination of these ingredients into the smallest complete prescription prenatal multivitamin available to date, which makes it an outstanding accomplishment. We continue to be committed to the growth and development of women's healthcare products designed to enhance the lives of patients, and to leading the way with innovative contributions to the prenatal market."

Source: TherapeuticsMD, Inc.